chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning her 8 year old daughter who on 12-NOV-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On that same day the patient complained of two pimple-like bumps, one on her neck and one on her chin. On 15-NOV-2007, there was a bunch of pimples on the patient's legs, thought to have been a rash due to chlorine (child on swim team). On 17-NOV-2007, the child was taken to a pediatrician who stated that the patient had chickenpox characterized by 18 lesions and a rash that was not itchy or scabby. The pediatrician noted that the patient was no longer contagious (given the timing), and to contact him if the rash worsens. The child does not have any other symptoms and was back at school normally. There did not appear to be any cases at school, but a male child had a rash, was sent home and had not returned. No further information is available.
vesicular rash, which was diagnosed as severe herpes zoster or shingles; The vaccine did not prevent shingles as intended; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age or gender. The patient's medical history, concurrent conditions and concomitant medication use were not provided.   On 04-JAN-2006, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dose, strength, administration route, anatomical location, lot number and expiration date were not reported) for routine adult health maintenance and for the long-term prevention of shingles at a medicine center.The reporter stated that the vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. Later in 2015, the patient was treated by a physician, for the onset of a vesicular rash, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles. The patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and would continue to suffer significant medical expenses, and pain and suffering, and other damages.
This spontaneous report was received from a pharmacist refers to an 54 year old female patient. Patient's pertinent medical history and drug reactions/allergies were not reported. The patient was not pregnant. On 06-JUN-2015 the patient was vaccinated with PNEUMOVAX 23 (.5 ml, unspecified frequency, lot # K009105, expiry date: 21-JAN-2016). Concomitant medications were not reported. Reporting pharmacist stated that the patient experienced redness, swelling, irritation and tenderness at the injection site after being vaccinated with PNEUMOVAX 23. No treatment was provided for the adverse events. Outcome of all the events was reported as recovering. Causality assessment was not provided. This is one of the three reports received from the same source (MARRS # 1506USA005260 and MARRS # 1506USA005495). Additional information has been requested.
I had a break through COVID-19 infection after I returned from vacation. Symptoms were like a bad cold: sore throat,  runny nose, cough. Over the counter DAYQUIL/NYQUIL seemed to clear it up seem to be reasonable. Health Dept. called in a script for Molmupiravir to take because it was a mild case of COVID-19.
Swelling under his left armpit; This spontaneous case was reported by a pharmacist and describes the occurrence of PERIPHERAL SWELLING (Swelling under his left armpit) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swelling under his left armpit). The patient was treated with IBUPROFEN on 14-Jan-2021 at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Swelling under his left armpit) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. The swelling was half the size it was, but still swollen at the time of report.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: No new information reported
Asthma attack/breathing problems; This is a spontaneous report from a contactable consumer (patient). A 67-years-old female patient received bnt162b2 (Pfizer/BioNTech COVID-19 vaccine), dose 1 intramuscular, administered in left arm on 19Mar2021 08:30 A.M. (Lot Number: EP7534), at the age of 67-years-old, as single dose for COVID-19 immunization. Medical history included hysterectomy from 1991, ongoing pancreatic cyst- benign, followed yearly, ongoing prolonged bleeding time, idiopathic, allergies: many dyes, shellfish, bandaids, nickel, Neosporin, artificial sugars (all are ongoing). Family medical history included Mother and Aunt- Lupus and lymphoma; Sister- Graves' disease and breast CA. The patient's concomitant medications were not reported. The patient stated that after the 1st shot, she had an asthma attack in the middle of the night on 19Mar2021. This was not typical for her. Treatment included Benadryl, orally from 20Mar2021 to 20Mar2021 for asthma attack, breathing problems after 1st vaccine at midnight. The event was reported as not serious. The patient underwent lab tests and procedures which included bleeding time prolonged, idiopathic on an unknown date. The outcome of the event was unknown. The patient received the 2nd dose on 09Apr2021 08:30 A.M. (Lot number: EW0153).
Vesicular rash on RUE (near site of injection) and throughout (face, chest, back, bilateral upper extremities) in various stages (some encrusted, some intact vesicles).
9 days, post vax, fever to 100.8F, left axilla pain, neck and back pain, malaise, anorexia, irritable, myalgias and headache. On 8/1/02, symptoms resolved.
Extreme soreness in left arm for 2 days after second dose, then had extreme soreness in right arm within another 2 days.  Made appt. with my primary care doctor and she sent me to ortho. doctor. I was diagnosed with adhesive capsulitis in right arm. Very low range of motion and very painful shoulder. No previous injuries to arms. My sister had the same reaction after her second dose in her left arm that received the injection.
pt recv vax 26FEB98 & mom states hives that afternoon for approx 3 days;notified MD observation only;
Information has been received from a nurse concerning a female patient who on unspecified date was vaccinated with the first dose of GARDASIL vaccine (Lot nor reported). Subsequently the patient experienced headache and stiffness. The patient called her physician. The nurse reported that the patient was not going to finish the series of GARDASIL vaccine. At the time of report the outcome of the patient was unknown. Additional information has been requested.
Flu-like symptoms of fever, malaise, myalgias, arthralgia, nausea, headache
Upper right arm swelled more than twice its normal size and became extremely red and extremely painful the first day. By the next morning my elbow and lower arm swelled also and was so bad I could not use or bend my arm. I had pain on the right side of my neck and throat that ran down my arm to my fingertips. This lasted for for 4 days before the swelling started going down. It took more than a week for me to get back to normal use. I did not go to the doctor because of snow.
Shortly after receiving her Flucelvax immunization, the patient started to experience heart racing, chest tightness, and visions changes, eventually followed by arm/leg numbness.  No anaphylaxis symptoms.  EMS was called and paramedics responded.  They found her BP 140/128 and blood sugar levels normal.  Patient was taken to Hospital for further evaluation due to arm numbness.  Patient has previously tolerated yearly flu shots with no adverse effects.
About 5-6 hours after vaccine was administered, patient noted that the left side of her face felt funny. This progressed to weakness and blurred vision on the left. The next morning she was doing better, but still had weakness and blurred vision. We will treat w/ steroids if it persists > 24 hours.
pt recvd vax & APAP 1030AM 31OCT94; pt slep 4PM t101.2 ax felt really hot; began have sz, vomited & fussing but not really responding well; taken to hosp ER-adm to hosp; mom described pt as slow, not self, stumbling w/t101;
This spontaneous report as received from a healthcare professional via field representative referred to a male patient of unknown age. On an unknown date the patient was vaccinated with PNEUMOVAX23 (Lot#, dose/frequency, route and duration were unspecified). It was indicated that patient couldn't move his arm after being administered PNEUMOVAX23. The outcome and causality were unknown. This is one of several report that received from the same source. Additional information has been requested.
Information has been received from a female consumer of unknown age, referring to herself. Information of the patient's medical history, concomitant therapy and current condition was not provided. In August 2013, the patient received PREVNAR (lot number, expiration date, dose, frequency and route unknown) for prophylaxis. In August 2016, the patient was vaccinated with PNEUMOVAX 23 (lot number, expiration date, dose, frequency and route unknown) for prophylaxis (inappropriate schedule of vaccine administered). No clinical adverse event was reported.
Febrile seizure. Was seen at ER. Normal white count, hemoglobin, platelets. Blood cult. drawn.
Fatigue and itchy, red rash directly below  injection site, appeared 3 days after injection. Rash area is approximately 2.5 inches by 5 inches. Notified pharmacy and Dr. Advised to take Benadryl.
PATIENT STATED THAT HE RECEIVED THE VACCINE ON FRIDAY, AT THE END OF THE DAY ON SATURDAY, HIS CHEST STARTED TO FEEL HEAVY AND HE HAS LABOR BREATHING. HE WOKE UP SUNDAY AND DIDN'T FEEL WELL. HE TOOK A NAP AT AROUND 4PM ,THEN WOKE UP AND COULDN'T BREATH WITH HEART PALPITATIONS. HE WAS ABLE TO ARRIVE TO THE EMERGENCY ROOM AND TRIED TO WALK HIMSELF IN. HE COLLAPSED ON THEIR YARD.
G45. TRANSIENT CEREBRAL ISCHEMIA 4/4/2023 DECONDITIONING I63.89 SUPERIOR CEREBELLAR ARTERY SYNDROME 5/3/2023 DECONDITIONING I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 4/17/2023 DECONDITIONING G45.9 TRANSIENT CEREBRAL ISCHEMIA 4/4/2023 ATHEROSCLEROSIS OF AORTA I63.89 SUPERIOR CEREBELLAR ARTERY SYNDROME 5/3/2023 ATHEROSCLEROSIS OF AORTA I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 4/17/2023 ATHEROSCLEROSIS OF AORTA
P/DTP & Polio number 2 on 23JAN87 pt cried all afternoon;
Information has been received from an office manager concerning an 8 year old female who on 20-AUG-2007 was vaccinated with Zostavax (Oka/Merck) instead of Varivax (Oka/Merck).  No adverse experience was reported.  Unspecified medical attention was sought.  It was also reported that the patient's sister also received a dose of Zostavax (Oka/Merck) instead of Varivax (Oka/Merck) (WAES # 0708USA04612).  Additional information has been requested.
DISCHARGE DIAGNOSES:  1. Covid 19 w/ symptoms of nausea, vomiting and diarrhea 2. Tobacco abuse 3. COPD - stable 4. Opioid dependency on Methadone program   HOSPITAL COURSE: ASSESSMENT & PLAN: 56-year-old woman with history notable for opiate dependence, now presents with nausea vomiting and diarrhea, initially thought likely consistent with gastroenteritis, but in turn it is related to Covid 19 and these were her initial symptoms.    Below is her plan of care she rec'd while hospitalized:   Gastroenteritis with N/V likely related to COVID-19: Patient presented with complaint of vomiting and diarrhea since 12 PM on 1/14/2022 Patient is on the methadone program and did not pick up her dose on 1/14/2022  Concerning foodborne source could have been a chicken salad sandwich she ate earlier that day Overall vital signs and labs are stable Viral gastritis versus withdrawal from missing dose of methadone or dx of COVID positive She has not been on any of antibiotics to consider C. Difficile Is not on oxygen so does not require steroids or qualify for toci/bari Plan:  o If has more diarrhea we will check for enteric pathogens - she has not had any further diarrhea o Advised to eat a bland type diet o Given paperwork on proning and Incentive spirometer to exercise your lung, do every hour x t0 rep o Antitussives, and mucolytic's as needed -these are over the counter o Frequent positional changes, ambulate and up in chair for all meals o Full barrier protection - quarenting for 10 days - till 1/23/2022   History of opioid dependence: On methadone program  Pharmacy validated and noted she did not pick up her "take out" dose on 1/14/2022 Plan:  o Resume outpatient methadone 150 mg daily   History of COPD: Patient is/was a 1/2 pk day smoker for years.  Continue w/ PTA albuterol inhaler and nebulizer as needed, Spiriva 2.5 mcg actuation inhaler 2 puffs daily Encouraged tobacco cessation especially now w/ Covid
Patient called 2 days after her vaccination and said she felt unwell the day after the vaccines. She said that she has a reaction at the injection site for the PNEUMOVAX, but not on the site where she got the FLUZONE. The reaction is slight swelling and "a red line that starts at the injection site and wraps around the front of the arm". She said she was taking aspirin for the inflammation and the pharmacist recommended adding diphenhydramine at bedtime since she didn't want to take it during the day.
Headache fatigue, weakness, numbness/tingling to LLE and left foot Narrative:  Seen in ED on 1/7 and given Ephederine for treatment of headaches
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX lot # L021215 exp. 10-JUN-2017 and lot # reported as "L019128" exp. "27-MAY-2017", (route and dose were not provided. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
patient received Hep B vaccine on 10-2-08. Patient awoke on 10-3-08 with hives located on scalp,arms,back,stomach and legs. patient also reported muscle soreness at site of injection (right deltoid). No other symptoms reported. Patient reports taking benadryl and zinc oxide applied to skin.
CHILD WAS AT CAMP AND SUDDENLY DEVELOPED OVERWHELMING SADNESS AND DEPRESSION. DEPRESSION, CRYING PROGRESSED OVER THE NEXT 4 DAYS. THIS LED CHILD TO QUESTION SUICIDE. SHE WAS TAKEN TO LOCAL ER AND ADMITTED TO AN INPATIENT MENTAL HEALTH HOSPITAL. SHE EXPERIENCED SEVERE DEPRESSION, DESPARATION, RACING THOUGHTS THAT WOULD NOT TURN OFF AND ANXIETY. SHE HAD TO BE PUT ON LEXAPRO AND SEROQUEL AND WAS DISCHARGED TO HOME 5 DAYS LATER. SHE IS NOW IN OUTPATIENT THERAPY.
Weakness in both arms started around 2:40 Thursday afternoon. The weakness in right arm subsided but continued in left arm until Monday evening. There has been swelling and redness in the upper left arm since Sunday still persists until now. There is also itching and redness around the upper left arm, injection sight.
On 9/15/19 - pt was in his room with dad - helping him clear off his desk when all of a sudden started spacing out and then had a seziure, lasting about 5 mins with 2 episodes of vomiting - 911 was called and taken to ER.
This spontaneous prospective pregnancy report as received from a registered nurse refers to unspecified number of female, expectant mothers of childbearing age (exact ages were not reported). Patients' concurrent conditions and medical history were not reported. On an unknown dates in the past, patients were vaccinated with the first dose of M-M-R II (dose, route of administration, lot number and expiration date were not reported). Other suspect therapies included RHOGAM (dose, frequency, route of administration, lot number, expiration date and indication were not reported) which was administered on an unknown dates. Concomitant therapy was not reported. On an unknown dates, patients became pregnant. The Last Menstrual Period (LMP) dates and Estimated Delivery Dates (EDD) were not reported. On an unknown dates, mothers were tested for rubella status and an unspecified number of mothers was found to have a diminished immunity to rubella component after receiving RHOGAM. The reporter stated that whether a mother was found to be immunodeficient to rubella component, mother was vaccinated with a second dose of M-M-R II (dose, route of administration, lot number and expiration date were not reported) before leaving office to treat the immunodeficiency (dates not reported). The outcome of the event was not reported. The pregnancy outcome was pending. The relatedness between the event and M-M-R II and RHOGAM was not reported. Additional information is not expected as the reporter refused additional contact.
Severe pain at injection site lasting 40 hours.  Headaches lasting 40 hours. Dizziness/vertigo occurred 3 times within 24 hours.  Fatigue lasting 40 hours.   Muscle and joint pain lasting 10 hours.
Lt thigh pain, swelling, inc warmth pain in joints; inflammation of joints; high pitched cry lasting >3 hrs; t100.6;
This case is a cluster of three patients who experienced adverse reactions following administration to DAPTACEL, lot number C4006AA. The other two patients were captured in cases 2012-03354 and 2012-03356. Initial report was received from a health care professional on 23 March 2012. A female patient had received a dose four intramuscular injection in the right arm of DAPTACEL, lot number C4006AA on an unknown date and the second day after the vaccine the patient experienced swelling, tenderness and redness of 5-10cm at the injection site. Medical history, concomitant medications, illness at the time of vaccination and any other vaccinations within four weeks of DAPTACEL were not reported. The patient's sister experienced the same adverse reaction to DAPTACEL where she experienced swelling, tenderness and redness of 5-10cm at the injection site, which was captured in case 2012-03354. The patient's outcome was not recovered. Documents held by sender: None.
Expired vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter reported that the expired date of vaccine was overlooked and accidentally administered to one of the  patient, who was the employe of same facility.  Concomitant drugs were not reported.  Treatment details were not given.   Most recent FOLLOW-UP information incorporated above includes: On 04-Apr-2022: Follow up received contains non-significant information-Reporter's contact details were updated.
ALLERGIC TO CONTRAST DYE FROM CT SCANS AND MRI AFTER GETTING COVID VACCINE; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight was 45.5 kilograms, and height was not reported. The patient's concurrent conditions included: secondary pulmonary hypertension. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. Concomitant medications included selexipag for pulmonary hypertension secondary, and sildenafil citrate. On an unspecified date, the patient experienced allergic to contrast dye from ct scans and mri after getting covid vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of allergic to contrast dye from ct scans and mri after getting covid vaccine was not reported. This report was non-serious. This case, involving the same patient is linked to 20230440127.
Kidney disorder; Kidney disorder; missed his 2nd dose; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient's wife). A male patient of an unspecified age received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date, as single dose, for COVID-19 immunisation. Medical history included renal transplant in 2013, ongoing renal disorder. Concomitant medications were not reported. The patient experienced kidney disorder on an unspecified date with outcome of unknown. The event caused patient's hospitalization. Due to this, the patient missed his 2nd dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained..
I was supposed to be given my first dose. They gave me the booster instead. I have had shortness of breath every day after the vaccination.
Pain near the injection site; Swelling near the injection site; Warmth near the injection site; Hardness near the injection site; Redness near the injection site; Headache; Fatigue; Nausea; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th May 2022, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced pain in arm, swelling arm, skin warm, induration, erythema of extremities, headache, fatigue and nausea. The patient was treated with paracetamol (Tylenol) and antibiotics nos (Antibiotics (Brand Names Not Known)). On an unknown date, the outcome of the pain in arm, swelling arm, skin warm, induration, erythema of extremities, headache, fatigue and nausea were unknown.   It was unknown if the reporter considered the pain in arm, swelling arm, skin warm, induration, erythema of extremities, headache, fatigue and nausea to be related to Shingrix.     Additional Information: GSK Receipt Date: 27-SEP-2022 Reporter's Comments:  The reporter was the patient.   The patient received her first dose of SHINGRIX and she experienced pain, swelling, warmth, hardness, and redness   near the injection site.   This area was the size of her palm.   She also experienced headache, fatigue , and nausea.   The patient took Tylenol to alleviate symptoms, and also was prescribed antibiotics (undefined). The reporter give consent to follow up. Additional supportive information: This case has been linked with the case US2022138685 reported by same reporter; Sender's Comments:  US-GSK-US2022138685:Same reporter
Given MMR and Varivax on 06/08/2005. 06/10/2005, fever for 2 days, today presented with fine maculopapular diffuse rash on trunk and extremities.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient was a friend of pharmacist's neighbour. On an unknown date the patient was vaccinated with ZOSTAVAX (lot #, expiration date, dose, frequency, route of administration and reason for use where not reported) after which the patient experienced an unspecified neurological issue. The outcome of an unspecified neurological issue is unknown. The relatedness between unspecified neurological issue and ZOSTAVAX was not reported. Additional information has been requested.
It lasted three days, I got really sick, migraine, nausea, dizziness.